Literature DB >> 8206323

Compartmentalization of type I 17 beta-hydroxysteroid oxidoreductase in the human ovary.

C Sawetawan1, L Milewich, R A Word, B R Carr, W E Rainey.   

Abstract

The steroid-metabolizing enzyme, type I 17 beta-hydroxysteroid oxidoreductase (17 beta-HSOR) also called 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) plays a key role in ovarian synthesis of 17 beta-estradiol. This is the only enzyme in the steroid-metabolizing pathway which has not been localized in the human ovary by immunohistochemistry. In this study, using antibody directed against human placental cytosolic 17 beta-HSOR (type I), a single protein band with a relative molecular mass of approximately 34 kDa was demonstrated by Western analysis in both human luteinized granulosa cells and placental tissue. In placental tissue, immunoreactive type I 17 beta-HSOR was demonstrated within the syncytiotrophoblast using immunohistochemistry. In human ovary, immunoreactive type I 17 beta-HSOR was localized exclusively in granulosa cells of developing follicles, ranging from primary follicles with a single layer of cuboidal-shaped granulosa cells, preantral follicles with multiple layers of granulosa cells, and large antral follicles. No immunoreactivity was detected in spindle-shaped granulosa cells of primordial follicles, theca interna, theca externa or surrounding stroma. In the corpus luteum, type I 17 beta-HSOR immunoreactivity was localized solely in granulosa-lutein cells. For comparison, immunoreactive 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) was examined in the same tissues. Both theca interna and granulosa cells of preantral and antral follicles exhibited 3 beta-HSD staining. Primary follicles did not exhibit detectable 3 beta-HSD in either granulosa or theca cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206323     DOI: 10.1016/0303-7207(94)90004-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Human adrenal cells that express both 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) and cytochrome b5 (CYB5A) contribute to adrenal androstenedione production.

Authors:  Yasuhiro Nakamura; Yewei Xing; Xiao-Gang Hui; Yumi Kurotaki; Katsuhiko Ono; Tony Cohen; Hironobu Sasano; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2010-12-23       Impact factor: 4.292

2.  17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.

Authors:  Anna Lutkowska; Andrzej Roszak; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

3.  Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene.

Authors:  Pia Rantakari; Leena Strauss; Riku Kiviranta; Heidi Lagerbohm; Jenni Paviala; Irma Holopainen; Seppo Vainio; Pirjo Pakarinen; Matti Poutanen
Journal:  Mol Endocrinol       Date:  2007-11-29

4.  Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression.

Authors:  M M Miettinen; M V Mustonen; M H Poutanen; V V Isomaa; R K Vihko
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

5.  Multiple sex-associated regions and a putative sex chromosome in zebrafish revealed by RAD mapping and population genomics.

Authors:  Jennifer L Anderson; Adriana Rodríguez Marí; Ingo Braasch; Angel Amores; Paul Hohenlohe; Peter Batzel; John H Postlethwait
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

6.  Expression and localization of estrogenic type 12 17beta-hydroxysteroid dehydrogenase in the cynomolgus monkey.

Authors:  Hong Liu; Shufang Zheng; Véronique Bellemare; Georges Pelletier; Fernand Labrie; Van Luu-The
Journal:  BMC Biochem       Date:  2007-02-05       Impact factor: 4.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.